未登录.png)
分享.png)
收藏分享 收藏 分享 收藏 The mRNA export pathway licenses viral mimicry response and antitumor immunity by actively exporting nuclear retroelement transcriptsmRNA输出通路通过主动输出核内逆转录元件转录本，调控病毒模拟反应和抗肿瘤免疫。
Wang, Xiaoqiang; Jin, Jiaxing; Yan, Han; Liu, Jinhua; Huang, Shan; Bai, Hui; Guo, Mingrui; Cheng, Xinyue; Deng, Ting; Ba, Yi; Gu, Yong; Gao, Xin; Hu, Deqing 分享 收藏 Regorafenib plus sintilimab as a salvage treatment for microsatellite stable metastatic colorectal cancer: a single-arm, open-label, phase II clinical trial瑞戈非尼联合信迪利单抗作为微卫星稳定型转移性结直肠癌的挽救治疗：一项单臂、开放标签、II期临床试验Liu, Rui; Ji, Zhi; Wang, Xia; Zhu, Lila; Xin, Jiaqi; Ma, Lijun; Zhang, Jiayu; Ge, Shaohua; Zhang, Le; Yang, Yuchong; Ning, Tao; Bai, Ming; Duan, Jingjing; Wang, Feixue; Sun, Yansha; Li, Hongli; Deng, Ting; Ba, Yi; Hao, Jihui 分享 收藏 Effect of comorbidity classes on survival of patients with gastrointestinal tract cancerGao, Linna; Yao, Tian; Ge, Shaohua; Cui, Jiuwei; Li, Wei; Guo, Zengqing; Xu, Hongxia; Weng, Min; Li, Suyi; Yao, Qinghua; Hu, Wen; Zhou, Lan; Chen, Junqiang; Wu, Xianghua; Zhao, Qingchuan; Li, Hongli; Shi, Hanping; Ba, Yi; Huang, He; Invest Nutr Status Clin Outcome Common Canc INSCOC Grp 分享 收藏 Multiomics reveals tumor microenvironment remodeling in locally advanced gastric and gastroesophageal junction cancer following neoadjuvant immunotherapy and chemotherapyJi, Zhi; Wang, Xia; Xin, Jiaqi; Ma, Lijun; Zuo, Duo; Li, Hongli; Su, Lan; Lv, Xinze; Ge, Shaohua; Zhang, Le; Liu, Yong; Zhang, Yanhui; Ding, Tingting; Deng, Ting; Ba, Yi; Liu, Rui 分享 收藏 First-line tislelizumab plus chemotherapy in gastric/ gastroesophageal junction cancer: RATIONALE-305 Asian SubgroupKato, K.; Bai, Y.; Shi, J.; Lee, K.; Wang, J.; Pan, H.; Rha, S.; Zhang, R.; Hirano, H.; Yamaguchi, K.; Guo, Z.; Ba, Y.; Yang, L.; Tsukuda, H.; Xu, Y.; Sheng, T.; Yang, S.; Li, L.; Oh, D.; Xu, R. 分享 收藏 A spatiotemporal comparative analysis on tumor immune microenvironment characteristics between neoadjuvant chemotherapy and preoperative immunotherapy for ESCCZhou, Zhengyang; Zhang, Hongdian; Du, Jian; Yang, Jiayu; Pan, Wen; Zhang, Qiumo; Wang, Huiya; Tang, Peng; Ba, Yi; Zhang, Haiyang 分享 收藏 A Phase 1a/1b Dose Escalation/Expansion Study of the Anti-PD-1 Monoclonal Antibody Nofazinlimab in Chinese Patients with Solid Tumors or LymphomaGong, Jifang; Guo, Ye; Zhang, Yanqiao; Ba, Yi; Chen, Tong; Li, Wei; Zhou, Caicun; Wang, Mengzhao; Yang, Haiyan; Zhou, Yuhong; Cai, Qiqing; Wang, Ziping; Huang, Gang; Zhang, Wei; Su, Rila; Cai, Zhongheng; Yue, Zenglian; Dou, Jinzhou; Li, Peiqi; Wu, Rachel; Tse, Archie N.; Shen, Lin 分享 收藏 Final analysis of camrelizumab plus chemotherapy for untreated advanced or metastatic esophageal squamous cell carcinoma: The ESCORT-1st trialcamrelizumab联合化疗治疗未经治疗的晚期或转移性食管鳞状细胞癌的最终分析: ESCORT-1st试验He, Mingming; Wang, Zhiqiang; Lu, Jin; Bai, Yuxian; Mao, Teng; Wang, Jun; Fan, Qingxia; Zhang, Yiping; Zhao, Kuaile; Chen, Zhendong; Gao, Shegan; Li, Jiancheng; Fu, Zhichao; Gu, Kangsheng; Liu, Zhihua; Wu, Lin; Zhang, Xiaodong; Feng, Jifeng; Niu, Zuoxing; Ba, Yi; Zhang, Helong; Liu, Ying; Zhang, Li; Min, Xuhong; Huang, Jing; Cheng, Ying; Wang, Dong; Sheng, Zhen; Zeng, Wanqin; Song, Li; Xu, Rui-Hua; Luo, Huiyan 分享 收藏 分享 收藏 分享 收藏 A real-world observation on thrombopoietic agents for patients with cancer treatment-induced thrombocytopenia in China: A multicenter, cross-sectional studyChen, Meiting; Li, Lu; Xia, Qing; Chen, Xiaobing; Liao, Zijun; Wang, Chang; Shen, Bo; Zhou, Min; Zhang, Qingyuan; Zhang, Yanqiao; Qian, Liting; Yuan, Xianglin; Wang, Zhehai; Xue, Cong; An, Xin; Liu, Bin; Gu, Kangsheng; Hou, Mei; Wang, Xiaojia; Wang, Wei; Li, Enxiao; Zhong, Jincai; Cheng, Jing; Shu, Yongqian; Yang, Nong; Wang, Huaqing; Yang, Runxiang; Liu, Tianshu; Deng, Ting; Ma, Fei; Liao, Wangjun; Qiu, Wensheng; Chen, Yu; Chen, Xi; Zhang, Mingzhi; Xu, Ruilian; Li, Xiaoling; Feng, Jifeng; Ba, Yi; Shi, Yanxia 分享 收藏 分享 收藏 Efficacy, safety and genomic analysis of SCT200, an anti-EGFR monoclonal antibody, in patients with fluorouracil, irinotecan and oxaliplatin refractory RAS and BRAF wild-type metastatic colorectal cancer: a phase II study抗EGFR单克隆抗体SCT200在氟尿嘧啶，伊立替康和奥沙利铂难治性RAS和BRAF野生型转移性结直肠癌患者中的疗效，安全性和基因组分析: II期研究Yang, Lin; Zhang, Wen; Fan, Nanfeng; Cao, Peiguo; Cheng, Ying; Zhu, Lingjun; Luo, Suxia; Zong, Hong; Bai, Yuxian; Zhou, Jianfeng; Deng, Yanhong; Ba, Yi; Liu, Tianshu; Aili, Mayinuer; Yin, Xianli; Gu, Kangsheng; Dai, Guanghai; Ying, Jieer; Shi, Jianhua; Gao, Yajie; Li, Wei; Yu, Guohua; Xie, Liangzhi; Gai, Wenlin; Wang, Yan; Meng, Peng; Shi, Yuankai 分享 收藏 Phase Ib study of anti-EGFR antibody (SCT200) in combination with anti-PD-1 antibody (SCT-I10A) for patients with RAS/BRAF wild-type metastatic colorectal cancer抗EGFR抗体 (SCT200) 联合anti-PD-1抗体 (SCT-I10A) 治疗RAS/BRAF野生型转移性结直肠癌的Ib期研究Bai, Ming; Lu, Yao; Shi, Chunmei; Yang, Jianwei; Li, Wei; Yin, Xianli; Huang, Chenghui; Shen, Lin; Xie, Liangzhi; Ba, Yi 分享 收藏 Advantig-105: Phase Ib dose-expansion study of ociperlimab (OCI) plus tislelizumab (TIS) with chemotherapy (CT) in patients (pts) with metastatic oesophageal squamous cell carcinoma (ESCC) and oesophageal adenocarcinoma (EAC)Sun, M.; Spigel, D. R.; Lee, Y-J.; Yoon, H.; Liu, Y.; Ahern, E.; Harris, S.; Lee, G-W.; Yan, D.; Chen, J.; Shiah, H-S.; Deng, T.; Zheng, H.; Tan, W.; Zhou, Z.; Wang, R.; Ba, Y. 分享 收藏 Third-line treatment patterns and clinical outcomes for metastatic colorectal cancer: a retrospective real-world study转移性结直肠癌的三线治疗模式及临床结局：一项回顾性真实世界研究Deng, Ting; Duan, Jingjing; Bai, Ming; Zhang, Le; Li, Hongli; Liu, Rui; Ning, Tao; Ge, Shaohua; Wang, Xia; Yang, Yuchong; Ji, Zhi; Wang, Feixue; Ba, Yi 分享 收藏 Safety, tolerability, and pharmacokinetics of an anti-LAG-3 antibody SHR-1802 in patients with advanced solid tumors: a phase I dose-escalation and dose-expansion studyDeng, Ting; Liu, Zhigang; Han, Zhengquan; Zhou, Huan; Liu, Rui; Li, Yijing; Li, Shaorong; Xiu, Peng; Wang, Shuni; Zhang, Yiping; Ba, Yi 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png)
EBIOMEDICINE.png)
OAAI